Patent US2223712A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4758596A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for therapeutic use of methyl tertiary-butyl ether

Assignee: RESEARCH Corp A NY NOT-FOR-PROFIT CORP
•
Filing: 1984-09-11
•
Granted: 1988-07-19
•
Expires: 2004-09-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Method for dissolving cholesterol calculus in vitro or in vivo comprising contacting the cholesterol calculus with methyl tertiary-butyl ether.

Inventors

  • 👤 Johnson L. Thistle
  • 👤 Mark J. Allen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 05:38
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/075; A61K31/08; A61B; A61B17/00; A61B17/22; A61B2017/22082; A61B2017/22084

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 14 words
A method for dissolving cholesterol calculus comprising contacting the calculus with methyl tertiary-butyl ether.
Claim 2
Independent Claim 14 words
A method for dissolving cholesterol calculus comprising contacting the calculus with methyl tertiary-butyl ether.
Claim 3
Dependent Claim 20 words
The method of claim 1 wherein the cholesterol calculus of a patient is contacted with methyl tertiary-butyl ether in vivo.
Claim 4
Dependent Claim 26 words
The method of claim 2 wherein the cholesterol calculus is selected from the group consisting of biliary duct stones, gallstones in the gallbladder and cholesterol plaque.
Claim 5
Dependent Claim 15 words
The method of claim 3 wherein the cholesterol calculus is a gallstone in the gallbladder.
Claim 6
Dependent Claim 22 words
The method of claim 1 wherein the cholesterol calculus is contacted with methyl tertiary-butyl ether in the biliary tract of the patient.
Claim 7
Dependent Claim 17 words
The method of claim 3 wherein the cholesterol calculus contacted with methyl tertiary-butyl ether is cholesterol plaque.
Claim 8
Dependent Claim 31 words
The method of claim 1 wherein in vivo agitation or stirring and aspiration of bile is utilized to facilitate distribution of the methyl tertiary-butyl ether and dissolving of the cholesterol calculus.
Claim 9
Independent Claim 20 words
A method for in vivo dissolving cholesterol calculus in a human patient comprising contacting the calculus with methyl tertiary-butyl ether.
Claim 10
Independent Claim 20 words
A method for in vivo dissolving cholesterol calculus in a human patient comprising contacting the calculus with methyl tertiary-butyl ether.
Claim 11
Dependent Claim 31 words
The method of claim 8 wherein in vivo agitation or stirring and removal of bile is utilized to facilitate distribution of the methyl tertiary-butyl ether and dissolving of the cholesterol calculus.
Claim 12
Dependent Claim 26 words
The method of claim 8 wherein the cholesterol calculus is selected from the group consisting of biliary duct stones, gallstones in the gallbladder and cholesterol plaque.
Claim 13
Dependent Claim 15 words
The method of claim 10 wherein the cholesterol calculus is a gallstone in the gallbladder.
Claim 14
Dependent Claim 13 words
The method of claim 1 wherein the cholesterol calculus is biliary duct stones.
Claim 15
Dependent Claim 12 words
The method of claim 1 wherein the cholesterol calculus is cholesterol plaque.
Claim 16
Dependent Claim 21 words
The method of claim 9 wherein bile is continuously or intermittently aspirated from the bile duct or gallbladder and not reinfused.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-07-19 1992-01-18 1992-07-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-07-19 1996-01-18 1996-07-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-07-19 2000-01-18 2000-07-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag